5:49 PM
Dec 26, 2012
 |  BC Extra  |  Financial News

Actinium raises $5.1M ahead of reverse-merger

Actinium Pharmaceuticals Inc. (Newark, N.J.) raised $5.1 million through the sale of about 9.3 million units in the first close of a bridge financing. Each unit comprises a share, a 120-day warrant to purchase a...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >